Health & Personal Care
HIGH
FDA DRUG
Glenmark Theophylline Extended-Release 400mg Recall Expanded for Failed Dissolution Tests (2025)
Glenmark Pharmaceuticals Inc. USA recalls theophylline extended-release 400 mg tablets after dissolution test failures. The recall covers 22,656 bottles distributed nationwide in the United States. Consumers should stop using the product and contact Glenmark for guidance.
Glenmark Pharmaceuticals Inc.
Failed Dissolution